Table 3.
Characteristics of the Study Population
| Variable | Overall, N (%) |
|---|---|
| Age, mean months (standard deviation) | 57.7 (49.5) |
| Female sex | 243 (46.9) |
| Race | |
| White | 261 (50.4) |
| Black | 160 (30.9) |
| Other | 97 (18.7) |
| Insurance | |
| Public | 299 (57.7) |
| Private | 218 (42.1) |
| Self pay/other | 11 (2.1) |
| Pneumonia history | 54 (10.4) |
| Asthma–wheezing history | 112 (21.6) |
| Pneumococcal vaccine | 491 (95) |
| Influenza vaccine | 461 (89.3) |
| Antibiotics at home | 100 (19.3) |
| Smoke exposure | 77 (14.9) |
| Hospitalized from emergency department | 225 (43.4) |
| Intensive care unit admission | 26 (11.6) |
| Length of stay ≥24 hours | 173 (76.9) |
| Length of stay ≥ 48 hours | 85 (37.8) |
| Broad-spectrum antibiotics | 70 (13.5) |
| Respiratory revisit within 72 hours of discharge | 11 (2.1) |
| Respiratory revisit with hospitalization | 8 (1.5) |